These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura].
    Author: Ling Y, Cao XS, Yu ZQ, Luo GH, Bai X, Su J, Dai L, Ruan CG.
    Journal: Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):184-8. PubMed ID: 17649712.
    Abstract:
    OBJECTIVE: To investigate the role of CD4+ CD25+ regulatory T (Treg) cells in patients with ITP. METHODS: Flow cytometry was used to examine the number of CD4+ CD25+, CD4+ CD25 high, CD4+ Foxp3+ and CD4+ CD25+ Foxp3+ T cells. The level of Foxp3 mRNA expression was analyzed by realtime quantitative reverse transcriptase polymerase chain reaction (RT-PCR) . CD4+ CD25 high T cells was cocultured with CD4+ CD25 - T cells from patients or controls for assessing the regulatory properties of CD4+ CD25 Treg cells. RESULTS: The proportion of CD4+ CD25+ T cells in the peripheral blood of patients with ITP [(15.64 +/- 5.82) %] was significantly higher than that in normal control group [(9.30 +/- 3.95)%] (P <0.01). There was no significant difference in the percentages of CD4+ CD25 high T cells between ITP patients and controls [(1.53 +/- 0.66)% versus (1.36 +/- 0.55)% (P = 0.317)]. But the number of CD4 Foxp 3+ T cells and CD4 + CD25+ Foxp3+ T cells in patients were significantly lower than that in control group (P <0.01). The expression of Foxp3 mRNA reduced (P < 0.01) and the suppressive activity of CD4+ CD25 high T cells is lower than that of healthy controls (P <0.01). CONCLUSION: In patients with ITP, both the number and immuno-regulative function of CD4+ CD25+ Treg cells are reduced.
    [Abstract] [Full Text] [Related] [New Search]